• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用一种刺激性单克隆抗体激活人血小板。

Activation of human platelets by a stimulatory monoclonal antibody.

作者信息

Kornecki E, Walkowiak B, Naik U P, Ehrlich Y H

机构信息

Department of Anatomy and Cell Biology, State University of New York Health Science Center, Brooklyn 11203.

出版信息

J Biol Chem. 1990 Jun 15;265(17):10042-8.

PMID:2351647
Abstract

The clinical significance of the interaction of antibodies with circulating platelets is well documented, but the mechanisms underlying these interactions are not fully known. Here we describe the characterization of anti-human platelet membrane protein monoclonal antibody (mAb) termed F11. Interaction of mAb F11 with human platelets resulted in dose-dependent granular secretion, measured by [14C]serotonin and ATP release, fibrinogen binding and aggregation. Analysis of the specific binding of mAb F11 to platelets revealed a high affinity site with 8,067 +/- 1,307 sites per platelet with a dissociation constant (Kd) of 2.7 +/- 0.9 x 10(-8) M. Two membrane proteins of 32,000 and 35,000 daltons, identified by Western blotting, were recognized by mAb F11. Incubation of 32Pi-labeled platelets with mAb F11 resulted in rapid phosphorylation of intracellular 40,000- and 20,000-dalton proteins, followed by dephosphorylation of these proteins. Monovalent Fab fragments or Fc fragments of mAb F11 IgG did not induce platelet aggregation or secretion; however, Fab fragments of mAb F11 IgG blocked mAb F11-induced platelet aggregation and the binding of 125I-mAb F11 to platelets. The addition of an anti-GPIIIa monoclonal antibody (mAb G10), which inhibits 125I-fibrinogen binding and platelet aggregation, completely blocked mAb F11-induced [14C]serotonin secretion and aggregation but not the binding of 125I-mAb F11 to platelets. mAb G10 also inhibited the increase in the phosphorylation of the 40,000- and 20,000-dalton proteins induced by mAb F11. These results implicate the involvement of the GPIIIa molecule in the chain of biochemical events involved in the induction of granular secretion.

摘要

抗体与循环血小板相互作用的临床意义已有充分记载,但这些相互作用的潜在机制尚不完全清楚。在此,我们描述了一种名为F11的抗人血小板膜蛋白单克隆抗体(mAb)的特性。mAb F11与人血小板的相互作用导致剂量依赖性颗粒分泌,通过[14C]血清素和ATP释放、纤维蛋白原结合和聚集来衡量。对mAb F11与血小板特异性结合的分析显示,每个血小板有8,067±1,307个高亲和力位点,解离常数(Kd)为2.7±0.9×10(-8)M。通过蛋白质印迹法鉴定出的两种分子量分别为32,000和35,000道尔顿的膜蛋白可被mAb F11识别。用mAb F11孵育32Pi标记的血小板导致细胞内40,000道尔顿和20,000道尔顿蛋白快速磷酸化,随后这些蛋白发生去磷酸化。mAb F11 IgG的单价Fab片段或Fc片段不诱导血小板聚集或分泌;然而,mAb F11 IgG的Fab片段可阻断mAb F11诱导的血小板聚集以及125I-mAb F11与血小板的结合。添加一种抑制125I-纤维蛋白原结合和血小板聚集的抗GPIIIa单克隆抗体(mAb G10),可完全阻断mAb F11诱导的[14C]血清素分泌和聚集,但不影响125I-mAb F11与血小板的结合。mAb G10还抑制了mAb F11诱导的40,000道尔顿和20,000道尔顿蛋白磷酸化的增加。这些结果表明,GPIIIa分子参与了颗粒分泌诱导过程中涉及的一系列生化事件。

相似文献

1
Activation of human platelets by a stimulatory monoclonal antibody.用一种刺激性单克隆抗体激活人血小板。
J Biol Chem. 1990 Jun 15;265(17):10042-8.
2
Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for monoclonal antibody F11 with the Fc gamma RII receptor.刺激性抗体激活血小板的机制:单克隆抗体F11的新型血小板受体与FcγRII受体的交联。
Biochem J. 1995 Aug 15;310 ( Pt 1)(Pt 1):155-62. doi: 10.1042/bj3100155.
3
Stimulatory antibody-induced activation and selective translocation of protein kinase C isoenzymes in human platelets.刺激抗体诱导人血小板中蛋白激酶C同工酶的激活和选择性易位。
Biochem J. 1995 Oct 15;311 ( Pt 2)(Pt 2):401-6. doi: 10.1042/bj3110401.
4
Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.PM6/13的功能特性,一种β3特异性(糖蛋白IIIa/CD61)单克隆抗体,相较于纤连蛋白与活化的人血小板结合,它对纤维蛋白原结合表现出优先抑制作用。
Thromb Haemost. 1998 Jan;79(1):177-85.
5
Anti-GPIIb/IIIa (CD41) monoclonal antibody-induced platelet activation requires Fc receptor-dependent cell-cell interaction.抗糖蛋白IIb/IIIa(CD41)单克隆抗体诱导的血小板活化需要Fc受体依赖性细胞间相互作用。
Br J Haematol. 1991 Sep;79(1):75-83. doi: 10.1111/j.1365-2141.1991.tb08010.x.
6
Inhibition of fibrin(ogen) binding to stimulated platelets by a monoclonal antibody specific for a conformational determinant of GPIIIa.一种针对糖蛋白IIIa构象决定簇的单克隆抗体对纤维蛋白(原)与活化血小板结合的抑制作用。
Thromb Res. 1990 Jun 15;58(6):577-92. doi: 10.1016/0049-3848(90)90304-u.
7
Interaction of two GPIIb/IIIa monoclonal antibodies with platelet Fc receptor (Fc gamma RII).两种糖蛋白IIb/IIIa单克隆抗体与血小板Fc受体(FcγRII)的相互作用。
Br J Haematol. 1991 May;78(1):80-6. doi: 10.1111/j.1365-2141.1991.tb04386.x.
8
Signaling pathways of the F11 receptor (F11R; a.k.a. JAM-1, JAM-A) in human platelets: F11R dimerization, phosphorylation and complex formation with the integrin GPIIIa.人血小板中F11受体(F11R;又名JAM-1、JAM-A)的信号通路:F11R二聚化、磷酸化以及与整合素GPIIIa形成复合物。
J Recept Signal Transduct Res. 2004 Feb;24(1-2):85-105. doi: 10.1081/rrs-120034252.
9
Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.三联蛋白。一种低分子量肽,可抑制纤维蛋白原与糖蛋白IIb-IIIa复合物上表达的血小板受体相互作用。
J Biol Chem. 1987 Nov 25;262(33):16157-63.
10
Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.与膜糖蛋白相关的人血小板IgG Fc受体的特性分析
J Clin Lab Immunol. 1995;46(1):1-11.

引用本文的文献

1
JAM-A: Adhesion Receptor and Signaling Regulator in Atherosclerosis.JAM-A:动脉粥样硬化中的黏附受体与信号调节因子
Curr Atheroscler Rep. 2025 Jul 29;27(1):75. doi: 10.1007/s11883-025-01322-x.
2
The distinct biological role of JAML positions it as a promising target for treating human cancers and a range of other diseases.JAML独特的生物学作用使其成为治疗人类癌症和一系列其他疾病的一个有前景的靶点。
Front Immunol. 2025 Jun 25;16:1558488. doi: 10.3389/fimmu.2025.1558488. eCollection 2025.
3
The activation of EP300 by F11R leads to EMT and acts as a prognostic factor in triple-negative breast cancers.
F11R 激活 EP300 导致 EMT,并作为三阴性乳腺癌的预后因素。
J Pathol Clin Res. 2023 May;9(3):165-181. doi: 10.1002/cjp2.313. Epub 2023 Feb 13.
4
Jam-A Unleashed Incites Thromboinflammatory Coronary Artery Disease.Jam-A释放引发血栓炎性冠状动脉疾病。
JACC Basic Transl Sci. 2022 May 23;7(5):462-464. doi: 10.1016/j.jacbts.2022.03.014. eCollection 2022 May.
5
The Long Non-Coding RNA HOXC-AS3 Promotes Glioma Progression by Sponging miR-216 to Regulate F11R Expression.长链非编码RNA HOXC-AS3通过海绵化miR-216调控F11R表达促进胶质瘤进展。
Front Oncol. 2022 Mar 23;12:845009. doi: 10.3389/fonc.2022.845009. eCollection 2022.
6
Infection Induces Lipopolysaccharide and Peptidoglycan Penetration Through Gingival Epithelium.感染诱导脂多糖和肽聚糖穿透牙龈上皮。
Front Oral Health. 2022 Feb 8;3:845002. doi: 10.3389/froh.2022.845002. eCollection 2022.
7
In Vitro Methods for Measuring the Permeability of Cell Monolayers.测量细胞单层通透性的体外方法
Methods Protoc. 2022 Feb 9;5(1):17. doi: 10.3390/mps5010017.
8
The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression.F11 受体(F11R)/连接黏附分子-A(JAM-A)(F11R/JAM-A)在癌症进展中的作用。
Mol Cell Biochem. 2022 Jan;477(1):79-98. doi: 10.1007/s11010-021-04259-2. Epub 2021 Sep 17.
9
Targeting Opposing Immunological Roles of the Junctional Adhesion Molecule-A in Autoimmunity and Cancer.靶向连接黏附分子-A 在自身免疫和癌症中的相反免疫作用。
Front Immunol. 2020 Nov 25;11:602094. doi: 10.3389/fimmu.2020.602094. eCollection 2020.
10
Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell-Cell Interactions in Tumor Progression.连接黏附分子在癌症中的作用:细胞-细胞相互作用在肿瘤进展中的多种功能范例。
Cancer Res. 2020 Nov 15;80(22):4878-4885. doi: 10.1158/0008-5472.CAN-20-1829. Epub 2020 Aug 14.